The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index; 21 of the 50 sources its claims cite were checked for support.
Promoting transparency and accountability towards anti-corruption in pharmaceutical procurement system: does e-procurement play a significant role?
Open accessAbstract
Purpose Understanding the interplay between transparency, accountability and e-procurement and their collective contribution to anti-corruption efforts in public procurement is crucial for developing effective strategies and policies. This research seeks to investigate whether e-procurement plays a significant role in enhancing transparency and accountability and subsequently reducing corruption risks in the public pharmaceutical procurement system. Design/methodology/approach The study employed a cross-sectional questionnaire survey to gather data from 274 procurement personnel and pharmacists working in 28 government-owned hospitals in the Southern Highlands of Tanzania. The collected data were then analysed using confirmatory factor analysis (CFA) and the Hayes PROCESS macro to test the study hypotheses. Findings The study findings revealed a negative and significant relationship between transparency and procurement corruption (ß = −0.117, p < 0.008). Moreover, accountability negatively and significantly affects procurement corruption (ß = −0.162, p = 0.006). Furthermore, the findings indicate that, at a high degree of e-procurement system implementation, transparency and accountability have a stronger impact on procurement anti-corruption measures. Practical implications Policymakers and decision-makers should implement robust mechanisms that enhance transparency, accountability and anti-corruption efforts. These may include providing clear and accessible information on procurement processes, efficient mechanisms for monitoring and reporting procurement irregularities and continuous improvement of e-procurement systems. By incorporating these measures and nurturing collaboration amongst procurement stakeholders, it becomes possible to foster a procurement environment characterised by integrity, fairness, accountability and reduced corruption. Originality/value Whilst previous studies delved into exploring the effect of transparency and accountability on procurement anti-corruption, the novelty of this study is the inclusion of e-procurement as a moderating variable in the relationship between transparency, accountability and anti-corruption. By so doing, this study adds to the existing body of knowledge regarding anti-corruption measures and offers valuable practical insights for policymakers and professionals aiming to enhance transparency, accountability and ethical conduct within the public pharmaceutical procurement system.
Overview
CoChat Summary
TL;DR
This cross-sectional survey of 274 procurement personnel and pharmacists in 28 Tanzanian government hospitals finds that transparency and accountability are negatively associated with pharmaceutical procurement corruption, and that e-procurement strengthens these negative relationships. The authors conclude that higher e-procurement implementation amplifies the anti-corruption effects of transparency and accountability.
Key findings
- Transparency had a negative and significant direct effect on procurement corruption (β = −0.117, p = 0.008), supporting H1.
- Accountability had a negative and significant direct effect on procurement corruption (β = −0.162, p = 0.006), supporting H2.
- E-procurement significantly moderated the transparency–corruption relationship (interaction β = −0.062, p = 0.013; R² change = 0.028) and the accountability–corruption relationship (interaction β = −0.084, p = 0.018; R² change = 0.039); effects were stronger at high e-procurement (+1 SD).
- The transparency model explained 27.1% of variation in anti-corruption (R² = 0.271), and the accountability model explained 31.1% (R² = 0.311).
Methods
- Cross-sectional questionnaire survey using an epistemological-positivism paradigm in the Southern Highlands of Tanzania (Rukwa, Songwe, Ruvuma, Njombe, Iringa and Mbeya), covering 28 government-owned hospitals: 1 referral, 5 regional and 22 district hospitals; data collected September–December 2022.
- Census approach among procurement officers and pharmacists; 308 respondents were initially identified, and 274 responses were analyzed (88.9% effective response rate), comprising 151 pharmacists (55.1%) and 123 procurement officers (44.9%).
- Confirmatory factor analysis (CFA) assessed the measurement model, and Hayes PROCESS macro v.4.2 tested direct and moderating effects; items used 5-point Likert-type scales.
Limitations
- Paper-stated: the study used a cross-sectional questionnaire survey with a sample consisting solely of procurement officers and pharmacists from government-owned hospitals in Tanzania; interviews and focus group discussions with other procurement stakeholders were not considered. The authors also state the findings are confined to the moderating role of e-procurement and recommend longitudinal/in-depth case studies and comparative studies between e-procurement and traditional systems.
- Evident from the text: the design is a self-administered, closed-question survey from a single country and region, so causal inference is limited, and the findings rely on respondents’ self-reported perceptions of corruption, transparency, accountability and e-procurement.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
11 Valid · 2 Not valid · 11 Not checked · 36 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“The final sample size included in the analysis was deemed adequate for the use of confirmatory factor analysis (CFA) and moderation effects which require a minimum sample size of 200 or more (Wolf et al., 2013;MacKinnon et al., 2002).”
§ Promoting transparency and accountability towards anticorruption in pharmaceutical procurement system: does e-procurement play a significant role? > 3.2 Sampling, sample size and data collection
What the sources say
- Disputedcites Wolf et al., 2013 sourceExperimental — accuracy not yet measured
The Discussion rejects a one-size-fits-all minimum: the CFA sample sizes studied ranged from 30 to 460, so 274 cannot be deemed adequate without considering the specific model. The Results also report CFA requirements both below and above 200. The paper does not establish a sample-size requirement for moderation effects. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
- Could not verifycites MacKinnon et al., 2002 sourceExperimental — accuracy not yet measured
The Simulation Description (page not supplied) lists 200 among several sample sizes used to study mediation methods; it does not identify 200 as a minimum. A search for CFA, moderation effects, and a minimum sample-size requirement found no passage supporting the claimed adequacy of 274 for those analyses. (LLM, conf=0.75)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Previous studies have recognised e-procurement systems as strategic tools for promoting transparency, accountability and anti-corruption in universal health service delivery (Mackey and Cuomo, 2020;Koller et al., 2020;Cholette et al., 2019).”
§ Promoting transparency and accountability towards anticorruption in pharmaceutical procurement system: does e-procurement play a significant role? > 2.2.3
What the sources say
- Partly supportedcites Mackey and Cuomo, 2020 sourceExperimental — accuracy not yet measured
The Results section, under “Medicines e-procurement systems” (page not supplied), describes e-procurement as increasing transparency and accountability and helping combat corruption in medicines procurement. It does not extend that finding to universal health service delivery generally. (LLM, conf=0.84)
- Partly supportedcites Koller et al., 2020 sourceExperimental — accuracy not yet measured
The “Corruption and procurement” section identifies e-procurement as an anti-corruption tool and discusses digital solutions for transparency and accountability in medicines procurement and supply. The paper connects anti-corruption measures to universal health coverage, but it does not extend its e-procurement discussion to universal health service delivery generally. No page number is available in our copy. (LLM, conf=0.85)
- Not checked — no full text of the sourcecites Cholette et al., 2019 source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Existing literature recognises the positive and significant role of transparency in reducing corruption in public health service delivery (Yang, 2018;Kohler and Dimancesco, 2020;Lega and Castellini, 2022).”
§ Promoting transparency and accountability towards anticorruption in pharmaceutical procurement system: does e-procurement play a significant role? > Promoting transparency and accountability
What the sources say
- Not checked — no full text of the sourcecites Yang, 2018 source
- Partly supportedcites Kohler and Dimancesco, 2020 sourceExperimental — accuracy not yet measured
The Results (‘Gaining policy traction’) report a growing consensus that greater transparency and accountability are more likely to reduce corruption. The paper focuses on pharmaceutical procurement, not public health service delivery generally, and the Results (‘Open contracting’) say transparency-related measures alone are insufficient. It does not establish a statistically significant effect. (LLM, conf=0.87)
- Not checked — no full text of the sourcecites Lega and Castellini, 2022 source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“By automating specific steps in pharmaceutical procurement system, e-procurement system reduces the potential for human interference and bias (Pentrakan et al., 2022;Tinali, 2022).”
§ Promoting transparency and accountability towards anticorruption in pharmaceutical procurement system: does e-procurement play a significant role? > 2.2.3
What the sources say
- Partly supportedcites Pentrakan et al., 2022 sourceExperimental — accuracy not yet measured
Our copy of Pentrakan et al. (2022) is a systematic review of price savings from e-bidding; its CONCLUSION does state that governments 'have had success using the e-bidding platforms for drug procurement to signal a greater openness to investigations, reduce corruption and reduce collusion with suppliers', and its data-extraction table reports for Raventós and Zolezzi (Chile) that 'the system supported price reductions through the reduction of fraud between purchasing officials and suppliers, effective rules that were more relevant to the use of online platforms'. That covers the 'less improper human involvement' half of the claim, but nothing in our copy attributes this to automating specific procurement steps, and neither 'human interference' nor 'bias' appears as a finding — the review's outcomes are price/procurement-cost reductions and factors (bid volume, location, contract, competitiveness, organization). So the automation mechanism and the bias element of the citing sentence are not supported by this source. (LLM, conf=0.65)
- Could not verifycites Tinali, 2022 sourceExperimental — accuracy not yet measured
Our copy of Tinali (2022) reviews e-procurement benefits only in general terms — 'increasing transparency, cost savings, reduction in procurement time and efforts, and improved convenience' (Technology Usage in Procurement) and a 'more competitive and more transparent environment' credited to Svidronova & Mikus (2015) (same section) — with no statement that automating steps reduces human interference or bias. The paper also deals with Tanzanian public procuring entities broadly and contains no pharmaceutical-procurement-specific finding (searched: 'human interference and bias', 'pharmaceutical procurement', 'corruption/discretion/manual intervention', 'automation minimizing human error'). No passage contradicts the claim either, so the attributed point is simply not addressed in our copy. (LLM, conf=0.60)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Consistent with existing literature (Kohler and Dimancesco, 2020;Koller et al., 2020;Mackey and Cuomo, 2020), the findings of this study recognise accountability as a fundamental and critical element in enhancing efforts to combat procurement corruption.”
§ Promoting transparency and accountability towards anticorruption in pharmaceutical procurement system: does e-procurement play a significant role? > 4.2.2 Accountability and procurement anti-corruption.
What the sources say
- Supportedcites Kohler and Dimancesco, 2020 source
The Abstract says better integration of accountability into procurement is needed to reduce corruption risk. The Results (‘Accountability’) also state that accountability can reduce corruption and other abuses. This supports the citing sentence’s characterization of accountability as a critical element in combating procurement corruption. (LLM, conf=0.92)
- Supportedcites Koller et al., 2020 source
The “Corruption and procurement” section describes the importance of integrating anti-corruption, transparency and accountability measures into pharmaceutical procurement governance. That supports the citing sentence’s background point that accountability matters to efforts against procurement corruption, although the paper discusses it as part of a combined approach in the pharmaceutical sector. (LLM, conf=0.85)
- Supportedcites Mackey and Cuomo, 2020 source
The Background says procurement decision points are susceptible to corruption in the absence of adequate transparency and accountability. The Discussion treats increasing accountability and fighting corruption in medicines procurement as primary objectives. The supplied passages do not specify page numbers. (LLM, conf=0.90)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
27 more claims
Create a free account to see all 60 claims and to verify the 1 reference still open.
- It may state two separate claims as one. 17
- Probably not a substantial claim. 15
- Borderline: one of the tests for a substantial claim is unclear. 1
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
“ACC*EPRT À0.084 0.056 À0.151 0.018 À0.301 À0.118”
§ Promoting transparency and accountability towards anticorruption in pharmaceutical procurement system: does e-procurement play a significant role? > 4.2.2 Accountability and procurement anti-corruption.
Reported -0.084 · recomputed 0.183
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
“TRANS*EPRT À0.062 0.062 À1.011 0.013 À0.358 À0.184”
§ Promoting transparency and accountability towards anticorruption in pharmaceutical procurement system: does e-procurement play a significant role? > 4.2.2 Accountability and procurement anti-corruption.
Reported -0.062 · recomputed 0.174
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
“ACC*EPRT À0.084 0.056 À0.151 0.018 À0.301 À0.118”
§ Promoting transparency and accountability towards anticorruption in pharmaceutical procurement system: does e-procurement play a significant role? > 4.2.2 Accountability and procurement anti-corruption.
Reported 0.151 · recomputed 1.5
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Promoting transparency and accountability towards anticorruption in pharmaceutical procurement system: does e-procurement play a significant role? > Promoting transparency and accountability
“H1.Transparency is negatively related to procurement corruption.”
§ Promoting transparency and accountability towards anticorruption in pharmaceutical procurement system: does e-procurement play a significant role? > 4.2.1 Transparency and procurement anti-corruption.
“In Model 1, H1 stated that "H1: transparency is negatively related to procurement anti-corruption".”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“EPRT 0.911 0.674 0.223 0.109 0.472 0.322 0.821 CRPT 0.896 0.636 0.155 0.052 0.394 0.283 0.525 0.797”
§ Promoting transparency and accountability towards anticorruption in pharmaceutical procurement system: does e-procurement play a significant role? > 4.2 Hypotheses testing and discussion
Reported 0.223 · recomputed 0.275625
1 more finding
Create a free account to see every finding of this check.
Citations
Cites
Evaluating Structural Equation Models with Unobservable Variables and Measurement Error
Fornell, C., & Larcker, D. F. (1981) · Journal of Marketing Research · doi:10.2307/3151312 · Cited by 109,314
Evaluating structural equation models with unobservable variables and measurement error
Fornell, C., & Larcker, D. F. (1981) · Journal of Marketing Research · doi:10.1177/002224378101800104 · Cited by 109,190
A comparison of methods to test mediation and other intervening variable effects
MacKinnon, D. P., Lockwood, C. M., Hoffman, J. M., West, S. G., & Sheets, V. (2002) · Psychological Methods · doi:10.1037/1082-989x.7.1.83 · Cited by 9,406
Assessing measurement model quality in PLS-SEM using confirmatory composite analysis
Hair, J. F., Howard, M. C., & Nitzl, C. (2020) · Journal of Business Research · doi:10.1016/j.jbusres.2019.11.069 · Cited by 5,446
Wolf, E. J., Harrington, K. M., Clark, S. L., & Miller, M. W. (2013) · Educational and Psychological Measurement · doi:10.1177/0013164413495237 · Cited by 3,931
Sarstedt, M., Ringle, C. M., Smith, D., Reams, R., & Hair, J. F. (2014) · Journal of Family Business Strategy · doi:10.1016/j.jfbs.2014.01.002 · Cited by 2,212
Applications of structural equation modeling (SEM) in ecological studies: an updated review
Fan, Y., Chen, J., Shirkey, G., John, R., Wu, S. R., Park, H., & Shao, C. (2016) · Ecological Processes · doi:10.1186/s13717-016-0063-3 · Cited by 1,466
Identifying Key Challenges Facing Healthcare Systems In Africa And Potential Solutions
Oleribe, O. E., Momoh, J., Uzochukwu, B. S., Mbofana, F., Adebiyi, A., Barbera, T., Williams, R., & Taylor Robinson, S. D. (2019) · International Journal of General Medicine · doi:10.2147/ijgm.s223882 · Cited by 685
Anti-corruption, transparency and accountability in health: concepts, frameworks, and approaches
Vian, T. (2020) · Global Health Action · doi:10.1080/16549716.2019.1694744 · Cited by 249
Beaulieu, M., & Bentahar, O. (2021) · Technological Forecasting and Social Change · doi:10.1016/j.techfore.2021.120717 · Cited by 195
Research works printed but not linked: 8
- 1989, Disciplined Inquiry: Understanding and Doing Educational Research
- 2022, Introduction to Mediation, Moderation, and Conditional Process Analysis: A Regression-Based Approach
- 2023, A review on participation of SMEs in public procurement: opportunities, challenges, and policy implications, New Applied Studies in Management, Economics and Accounting, 6, 18
- 2022, The effect of transparency principles and e-procurement on the function of the internal control systems and the impact on financial accountability, International Journal of Management Studies and Social Science Research, 4, 161
- 2019, Research Methods for Business Students
- UNODC, 2013, Guidebook on Anti-corruption in Public Procurement and the Management of Public Finances
- URT, 2013, The Public Procurement Regulations (As Amended in 2016)
- URT, 2022, Demographic and Health Survey and Malaria Indicator Survey
Cited by
Zumitzavan, V., Prachumrasee, K., & Pathak, S. (2025) · Journal of Open Innovation Technology Market and Complexity · doi:10.1016/j.joitmc.2025.100626 · Cited by 34
Save life! Optimization of dynamics for pharmaceutical distribution performance
Mwakyeja, B., & Kimario, H. F. (2024) · Management Matters · doi:10.1108/manm-03-2024-0018 · Cited by 14
Israel, B. (2024) · Management Decision · doi:10.1108/md-08-2023-1338 · Cited by 14
Self-citationUnveiling the complexity of civil service effectiveness index: An asymmetric and ANN modeling
Jilani, M. M. A. K., Rahman, M. M., Latif, M. A., & Ahmed, N. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e39776 · Cited by 13
Oversight mechanisms and public accountability in an emerging economy
Makanga, C. N., Orobia, L. A., Kaawaase, T. K., Nabeta, I. N., Mindra, R. K., & Munene, J. C. K. (2025) · Cogent Business & Management · doi:10.1080/23311975.2025.2507216 · Cited by 13
“…as instrument items of previous scholars adapted to the study context (chaparro-peláez et al., 2022; hapugoda et al., 2022; Knight & cross, 2012; Mahuwi & israel, 2024). the main predictor variable of oversight mechanisms was measured based on four dimensions, namely internal audit reviews,…”
Metadata
- Authors
- Mahuwi, L., & Israel, B.
- Affiliations
- College of Business Education (TZ)
- Corresponding author
- Israel, Baraka
- Venue
- Management Matters
- Publisher
- Emerald
- Published
- 2024-01-03
- Volume
- 21
- Issue
- 1
- Pages
- 20-37
- ISSN
- 2279-0187 (ISSN-L)
- 2752-8359
- OpenAlex
- W4390488621
- Cited by
- 25
- References
- 48
- Citations by year
- 2026: 12 · 2025: 9 · 2024: 4
- FWCI
- 8.45
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- cc-by
- www.emerald.com/insight/site-policies (tdm)
- Locations
- Management Matters (publishedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Social Sciences › Business, Management and Accounting › Strategy and Management › Public Procurement and Policy
- Social Sciences › Sociology and Political Science › Corruption and Economic Development
- Social Sciences › Decision Sciences › Management Science and Operations Research › Auction Theory and Applications
- Keywords
- e-procurement, transparency, accountability, anti-corruption, public procurement, drug procurement, public hospitals, corruption risk, moderating effect
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Promoting transparency and accountability towards anti-corruption in pharmaceutical procurement system: does e-procurement play a significant role? https://app.cochat.ai/papers/10.1108/manm-07-2023-0027
- The paper
- Mahuwi, L., & Israel, B. (2024). Promoting transparency and accountability towards anti-corruption in pharmaceutical procurement system: does e-procurement play a significant role? Management Matters. https://doi.org/10.1108/manm-07-2023-0027
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.



